Hrt Financial LP 23and Me Holding Co. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.36 - $0.61 $150,978 - $255,824	419,384 New	419,384 $163,000
Q4 2023 Feb 09, 2024	BUY	$0.71 - $0.97 $290,347 - $396,671	408,940 New	408,940 $373,000
Q2 2023 Aug 11, 2023	SELL	$1.59 - $2.29 $52,326 - $75,363	-32,910 Reduced 47.54%	36,320 $63,000
Q1 2023 May 12, 2023	BUY	$2.05 - $2.87 $141,921 - $198,690	69,230 New	69,230 $157,000
Q3 2021 Nov 15, 2021	SELL	$7.29 - $11.0 $1.06 Million - $1.6 Million	-145,681 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.87 - $13.32 $1.44 Million - $1.94 Million	145,681 New	145,681 $1.7 Million

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.